CH366546A - Verfahren zur Herstellung von Methylen-5-(p-amino-benzolsulfonylamido)-1-phenyl-pyrazol - Google Patents
Verfahren zur Herstellung von Methylen-5-(p-amino-benzolsulfonylamido)-1-phenyl-pyrazolInfo
- Publication number
- CH366546A CH366546A CH5866158A CH5866158A CH366546A CH 366546 A CH366546 A CH 366546A CH 5866158 A CH5866158 A CH 5866158A CH 5866158 A CH5866158 A CH 5866158A CH 366546 A CH366546 A CH 366546A
- Authority
- CH
- Switzerland
- Prior art keywords
- phenyl
- pyrazole
- methylene
- preparation
- aminobenzenesulfonylamido
- Prior art date
Links
- 238000002360 preparation method Methods 0.000 title claims description 5
- 238000000034 method Methods 0.000 title claims description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 claims description 13
- 239000002253 acid Substances 0.000 claims description 4
- 150000007513 acids Chemical class 0.000 claims description 4
- -1 methylene-5- (p-amino-benzenesulfonamido) -1-phenyl-pyrazole Chemical compound 0.000 claims description 2
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Chemical compound OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- VKYKSIONXSXAKP-UHFFFAOYSA-N hexamethylenetetramine Chemical compound C1N(C2)CN3CN1CN2C3 VKYKSIONXSXAKP-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 2
- 239000000825 pharmaceutical preparation Substances 0.000 description 2
- HFFXLYHRNRKAPM-UHFFFAOYSA-N 2,4,5-trichloro-n-(5-methyl-1,2-oxazol-3-yl)benzenesulfonamide Chemical compound O1C(C)=CC(NS(=O)(=O)C=2C(=CC(Cl)=C(Cl)C=2)Cl)=N1 HFFXLYHRNRKAPM-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 239000001828 Gelatine Substances 0.000 description 1
- 229930040373 Paraformaldehyde Natural products 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000012876 carrier material Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 239000008098 formaldehyde solution Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 239000004312 hexamethylene tetramine Substances 0.000 description 1
- 235000010299 hexamethylene tetramine Nutrition 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 229920002866 paraformaldehyde Polymers 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 229920001515 polyalkylene glycol Polymers 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- FDDDEECHVMSUSB-UHFFFAOYSA-N sulfanilamide Chemical compound NC1=CC=C(S(N)(=O)=O)C=C1 FDDDEECHVMSUSB-UHFFFAOYSA-N 0.000 description 1
- QWCJHSGMANYXCW-UHFFFAOYSA-N sulfaphenazole Chemical compound C1=CC(N)=CC=C1S(=O)(=O)NC1=CC=NN1C1=CC=CC=C1 QWCJHSGMANYXCW-UHFFFAOYSA-N 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 235000012222 talc Nutrition 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/38—Nitrogen atoms
- C07D231/42—Benzene-sulfonamido pyrazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH5866158A CH366546A (de) | 1958-04-23 | 1958-04-23 | Verfahren zur Herstellung von Methylen-5-(p-amino-benzolsulfonylamido)-1-phenyl-pyrazol |
| ES0248157A ES248157A1 (es) | 1958-04-23 | 1959-03-25 | Procedimiento para la obtenciën de un nuevo derivado sulfonamidico |
| FR835239A FR116M (fr) | 1958-04-23 | 1960-08-08 | Nouveau dérivé sulfonamidique utilisable en thérapeutique. |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH5866158A CH366546A (de) | 1958-04-23 | 1958-04-23 | Verfahren zur Herstellung von Methylen-5-(p-amino-benzolsulfonylamido)-1-phenyl-pyrazol |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH366546A true CH366546A (de) | 1963-01-15 |
Family
ID=4521837
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH5866158A CH366546A (de) | 1958-04-23 | 1958-04-23 | Verfahren zur Herstellung von Methylen-5-(p-amino-benzolsulfonylamido)-1-phenyl-pyrazol |
Country Status (3)
| Country | Link |
|---|---|
| CH (1) | CH366546A (es) |
| ES (1) | ES248157A1 (es) |
| FR (1) | FR116M (es) |
-
1958
- 1958-04-23 CH CH5866158A patent/CH366546A/de unknown
-
1959
- 1959-03-25 ES ES0248157A patent/ES248157A1/es not_active Expired
-
1960
- 1960-08-08 FR FR835239A patent/FR116M/fr active Active
Also Published As
| Publication number | Publication date |
|---|---|
| ES248157A1 (es) | 1960-04-16 |
| FR116M (fr) | 1961-01-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CH366546A (de) | Verfahren zur Herstellung von Methylen-5-(p-amino-benzolsulfonylamido)-1-phenyl-pyrazol | |
| AT213899B (de) | Verfahren zur Herstellung des neuen 3-(p-Amino-benzolsulfonamido)-6-oxy-pyridazins und seiner Salze | |
| AT112135B (de) | Verfahren zur Darstellung von basischen Oximäthern und ihren Salzen. | |
| DE1144730B (de) | Verfahren zur Herstellung eines Sulfonamidderivates | |
| DE706578C (de) | Verfahren zur Gewinnung von Praeparaten, die das Kreislaufhormon Kallikrein enthalten | |
| AT100211B (de) | Verfahren zur Darstellung neuer organischer Arsenverbindungen. | |
| DE539806C (de) | Verfahren zur Darstellung von Isopropylallylbarbitursaeure | |
| DE488891C (de) | Verfahren zur Darstellung von N-substituierten Arsenobenzimidazolonen | |
| AT216522B (de) | Verfahren zur Herstellung des neuen N-3,4-Dimethylbenzolsulfonyl-N'-tetramethylenharnstoffs | |
| DE261875C (es) | ||
| DE655530C (de) | Verfahren zur Darstellung von N-Methyl-C, C-allylisopropylbarbitursaeure | |
| DE954994C (de) | Verfahren zur Herstellung von Komplex-Eiweissverbindungen der Metallkomplexe der Chlorophyll- und Porphyrin-Reihe | |
| DE719026C (de) | Verfahren zur Herstellung von Praeparaten, die das Kreislaufhormon Kallikrein enthalten | |
| DE491681C (de) | Verfahren zur Darstellung von Jodsubstitutionsprodukten von Pyridinderivaten | |
| DE568339C (de) | Verfahren zur Herstellung eines silberhaltigen Praeparates aus AEthylendiamin | |
| DE537896C (de) | Verfahren zur Darstellung von Arsinsaeuren der Pyridinreihe | |
| DE519531C (de) | Verfahren zur Herstellung einer leicht wasserloeslichen, kolloidalen Silber-Tannin-Eiweissverbindung | |
| AT132187B (de) | Verfahren zur Herstellung eines kristallisierten Digitalisglucosides. | |
| AT54778B (de) | Verfahren zur Gewinnung von Immunstoffen. | |
| DE262328C (es) | ||
| DE904651C (de) | Verfahren zur Herstellung von Halogenaryloxyketonen und Halogenarylthioketonen | |
| DE495336C (de) | Verfahren zur Darstellung von basischen Oximaethern und ihren Salzen | |
| CH367182A (de) | Verfahren zur Herstellung von 3-(p-Amino-benzolsulfonamido)-6-oxy-pyridazin | |
| CH125889A (de) | Verfahren zur Darstellung von 2.4-Dioxy-5-heptylbenzoesäure. | |
| CH377832A (de) | Verfahren zur Herstellung von 3-(p-Amino-benzolsulfonamido)-6-oxy-pyridazin |